Literature DB >> 3982036

Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer.

T Brümmendorf, F A Anderer, H J Staab, A Hornung, E Stumpf, G Kieninger.   

Abstract

In a clinical study of observed postoperative survival of colorectal cancer patients, we investigated the application of a risk score based on tumor-related prognostic parameters. Six hundred seventy-four patients have been registered for primary surgery of colorectal cancer since 1974 who did not receive further postoperative treatments. The prognostic parameters included operability, tumor extension, and preoperative serum carcinoembryonic antigen (CEA) level. The scoring system was based on the average death-rate ratios of subgroups of patients and their age and sex-matched reference groups derived from the general life table of the population of the Federal Republic of Germany. The individual score sums of the patients exhibited score sum ranges which characterized groups of patients with entirely different observed survival. The prediction of individual survival after primary operation was only partly possible. In the plot of individual survivals vs individual score sums, a marginal risk zone was obtained which evidently represents the zone of maximum expected survival of patients who do not receive further postoperative treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3982036     DOI: 10.1002/jso.2930280405

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Preoperative serum levels of CEA and CA 242 in colorectal cancer.

Authors:  M Carpelan-Holmström; C Haglund; P Kuusela; H Järvinen; P J Roberts
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

2.  Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.

Authors:  M Carpelan-Holmström; C Haglund; J Lundin; H Alfthan; U H Stenman; P J Roberts
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.